APA (7th ed.) Citation

Sooi, K., Danchaivijtr, P., Wong, C. K., Tu, V. D., Sachdeva, M., Tai, B. C., & Soo, R. A. (2026). An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib. Thoracic Cancer, 17(13), 1. https://doi.org/10.1111/1759-7714.70331

Chicago Style (17th ed.) Citation

Sooi, Kenneth, Pongwut Danchaivijtr, C. K. Wong, V. D. Tu, Manavi Sachdeva, B. C. Tai, and Ross A. Soo. "An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib." Thoracic Cancer 17, no. 13 (2026): 1. https://doi.org/10.1111/1759-7714.70331.

MLA (9th ed.) Citation

Sooi, Kenneth, et al. "An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib." Thoracic Cancer, vol. 17, no. 13, 2026, p. 1, https://doi.org/10.1111/1759-7714.70331.